Patent US4320134A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4320134A Expired / Lapsed US ⏱️ 0.0 years remaining

Inhibiton of thromboxane synthetase with 1-substituted imidazole compounds

Assignee: Kissei Pharmaceutical Co Ltd
•
Filing: 1979-02-21
•
Granted: 1982-03-16
•
Expires: 1999-02-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The imidazole compounds of the general formula (I): ##STR1## wherein Y is a carboxyl group, a hydroxymethyl group, an N-di or -mono alkyl substituted or unsubstituted carbamoyl group, a cyano group, or an N-di or -mono alkyl substituted or unsubstituted aminomethyl group, and n is an integer of 3 to 20; and pharmaceutically acceptable salts thereof. These compounds have a strong inhibitory effect on thromboxane synthetase from rabbit platelet microsomes, and are useful as therapeutically active agents for inflammation, hypertension, thrombus, cerebral apoplexy and asthma.

Inventors

  • 👤 Kinji Iizuka
  • 👤 Kenji Akahane
  • 👤 Yukio Kamijo
  • 👤 Denichi Momose
  • 👤 Yukiyoshi Ajisawa

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 04:24
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/10; C07D231/12; C07D233/00; C07D233/54; C07D233/56; C07D249/00; C07D249/02; C07D249/08

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 25 words
A compound of the formula: ##STR13## wherein Y is carboxyl, and n is an integer of 6 to 9 or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 25 words
A compound of the formula: ##STR13## wherein Y is carboxyl, and n is an integer of 6 to 9 or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 9 words
The compound of claim 1, wherein n is 6.
Claim 4
Dependent Claim 9 words
The compound of claim 1, wherein n is 7.
Claim 5
Dependent Claim 9 words
The compound of claim 1, wherein n is 8.
Claim 6
Dependent Claim 9 words
The compound of claim 1, wherein n is 9.
Claim 7
Dependent Claim 35 words
A pharmaceutical composition comprising a compound of claim 1 as an active ingredient in an amount effective for the treatment of a disease caused by thromboxane A 2 and a pharmaceutically acceptable carrier or diluent.
Claim 8
Dependent Claim 29 words
The pharmaceutical composition of claim 6 wherein the compound of claim 1 is present in an amount effective for the treatment of inflammation, hypertension, thrombus, cerebral apoplexy or asthma.
Claim 9
Dependent Claim 14 words
The pharmaceutical composition of claim 6 or 7 wherein said active ingredient is 1-(7-carboxyheptyl)-imidazole.
Claim 10
Independent Claim 79 words
A method for treating inflammation comprising administering a therapeutically effective amount of a compound of the formula: ##STR14## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 11
Independent Claim 79 words
A method for treating inflammation comprising administering a therapeutically effective amount of a compound of the formula: ##STR14## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 12
Independent Claim 79 words
A method for treating hypertension comprising administering a therapeutically effective amount of a compound of the formula: ##STR15## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 13
Independent Claim 79 words
A method for treating hypertension comprising administering a therapeutically effective amount of a compound of the formula: ##STR15## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 14
Independent Claim 79 words
A method for treating thrombus comprising administering a therapeutically effective amount of a compound of the formula: ##STR16## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 15
Independent Claim 79 words
A method for treating thrombus comprising administering a therapeutically effective amount of a compound of the formula: ##STR16## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 16
Independent Claim 80 words
A method for treating cerebral apoplexy comprising administering a therapeutically effective amount of a compound of the formula: ##STR17## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 17
Independent Claim 80 words
A method for treating cerebral apoplexy comprising administering a therapeutically effective amount of a compound of the formula: ##STR17## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 18
Independent Claim 79 words
A method for treating asthma comprising administering a therapeutically effective amount of a compound of the formula: ##STR18## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 19
Independent Claim 79 words
A method for treating asthma comprising administering a therapeutically effective amount of a compound of the formula: ##STR18## to a subject afflicted with the same, wherein Y is carboxyl, hydroxymethyl, N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted carbamoyl, cyano or N-di or -mono straight or branched chain C 1 -C 4 alkyl substituted or unsubstituted aminomethyl, and n is an integer of 3 to 20, or a pharmaceutically acceptable salt thereof.
Claim 20
Dependent Claim 15 words
The method of claim 9, 10, 11, 12 or 13 wherein said compound is 1-(7-carboxyheptyl)-imidazole.

References Cited (Backward Citations)

US3531494A Cited
US3767602A Cited
US3912689A Cited
DE2638470A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-03-15 1985-09-14 1986-03-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-03-15 1989-09-14 1990-03-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-03-15 1993-09-14 1994-03-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag